It is possible that SARS-CoV2 contributes to the immunopathology of SS, not only through TLR7 signaling, but also through other pattern recognition receptor signaling pathways, such as the activation of the cGAS-STINK pathway which can be activated by DNA that emerges from a collateral host response to viral tissue damage (135). This evidence concerns the gene TLR7 and synovial sarcoma.